Moderna Vaccine Lab Results Strong Against Delta Variant By Investing.com
By Christiana SciaudoneInvesting.com -- Moderna (NASDAQ:MRNA) rose almost 6% after saying its Covid-19 vaccine may be effective against variants, including the delta strain that is rapidly spreading. The mRNA vaccine produced neutralizing antibodies against all variants tested, including the delta, beta and eta, the company said in a statement. The vaccine was also authorized for use in India, where the delta variant may be responsible for the outbreak, CNBC said. The shares hit a 52-week high in morning trading, at $238.40. “As we seek to defeat the pandemic, it is imperative that...
Подробнее